If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
19 April 2022 A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.
10 March 2017 The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.
8 January 2016 US-based gene sequencing company Illumina has claimed that The Doctors Laboratory’s use of the Harmony prenatal test provided by Ariosa Diagnostics infringes its patent.